tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Drew Jones, 19 are a BUY (73.08%), 7 are a HOLD (26.92%).
Analyst Drew Jones, currently employed at STEPHENS, carries an average stock price target met ratio of 94.67% that have a potential upside of 36.26% achieved within 418 days. Previously, Drew Jones worked at DEUTSCHE BANK.
Drew Jones’s has documented 61 price targets and ratings displayed on 12 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on LGND, Ligand Pharmaceuticals at 03-May-2019.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $54 was fulfilled within 1 day with a profit of $0.99 (1.8%) receiving and performance score of 18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 20-Jan-2026
$105
$1.62 (1.57%)
$85
1 months 9 days ago
(20-Jan-2026)
2/3 (66.67%)
$2.65 (2.59%)
101
Hold Since 05-Jan-2026
$105
$1.62 (1.57%)
$68
1 months 24 days ago
(05-Jan-2026)
9/11 (81.82%)
$3.39 (3.34%)
259
Hold Since 25-Nov-2025
$105
$1.62 (1.57%)
$75
3 months 4 days ago
(25-Nov-2025)
9/13 (69.23%)
$3.87 (3.83%)
406
Hold Since 24-Nov-2025
$105
$1.62 (1.57%)
$85
3 months 5 days ago
(24-Nov-2025)
22/24 (91.67%)
$3.99 (3.95%)
194
Hold Since 22-Feb-2023
$105
$1.62 (1.57%)
$90
3 months 5 days ago
(24-Nov-2025)
8/9 (88.89%)
$3.99 (3.95%)
265
What Year was the first public recommendation made by Drew Jones?
